LakePharma Announces Dedicated Vector Center to Support Gene and Cell TherapyAdded On: 2019-02-26
LakePharma Announces its GMP Biorepository Facility near Boston is Now Operational, Plans Additional HiringAdded On: 2019-01-15
LakePharma announces its cGMP microBiomanufacturing Center is now operationalAdded On: 2018-12-18
Added On: 2013-07-05
LakePharma published an article in the journal BMC Biotechnology entitled "Monoclonal antibody humanness score and its applications."
The article describes LakePharma's new method to quantify the humanness of the variable region sequences of monoclonal antibodies. Using LakePharma's tool, the "T20 score analyzer," users are able to clearly distinguish human and non-human antibodies with excellent specificity. The T20 score analyzer is available for free use online: http://abAnalyzer.lakepharma.com.
Click here to view the full article in BMC Biotechnology.